NCT06439485
- Conditions
- Advanced Cholangiocarcinoma, FGFR2 Fusion
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
FGFR2 Fusion
Explore clinical trials studying FGFR2 Fusion. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
FGFR2 Fusion trial results
Completed
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
NCT04919642
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Providence Cancer Center Anchorage, Alaska, United States
- City of Hope Duarte, California, United States
- University of California, Los Angeles, School of Medicine Santa Monica, California, United States
- USO Oncology Network- Rocky Mountain Cancer Centers Denver, Colorado, United States